PMID- 34956499 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20211228 IS - 1943-8141 (Print) IS - 1943-8141 (Electronic) IS - 1943-8141 (Linking) VI - 13 IP - 11 DP - 2021 TI - Clinical efficacy of thoracoscopic surgery by subxiphoid approach for thymoma and its influence on intraoperative blood loss and postoperative complications. PG - 12843-12851 AB - OBJECTIVE: To evaluate the clinical efficacy of thoracoscopic surgery by subxiphoid approach for patients with thymoma and its influence on intraoperative blood loss and postoperative complications. METHODS: From January 2019 to January 2020, 90 patients who underwent thoracoscopic surgery were enrolled and evenly divided into a control group receiving surgery by lateral thoracic approach and an experimental group adopting the subxiphoid approach according to different surgical approaches, and their clinical data were retrospectively analyzed. The clinical efficacy, perioperative indexes, postoperative complications, pulmonary function, and inflammatory factors were compared between the two groups. Generic Quality of Life Inventory-74 (GQOLI-74) was used to assess the quality of life of the patients before and after surgery, and Mini-Mental State Examination (MMSE) was used to assess their mental state. The Numerical Rating Scale (NRS) was used to evaluate the postoperative pain of the two groups. RESULTS: After treatment, the total clinical effectiveness rate of the experimental group was significantly higher than that of the control group (P<0.05). The experimental group obtained superior results in perioperative index and fewer postoperative complications compared with the control group (P<0.05). Better performance of FEV1 and FVC was observed in the experimental group than the control group (P<0.05). The experimental group had significantly higher postoperative GQOLI-74 scores (P<0.001) and MMSE scores (P<0.05) than the control group. Lower levels of C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-alpha), and lower NRS scores at 12 h and 24 h after surgery were witnessed in the experimental group compared to the control group (P<0.05). CONCLUSION: For patients with thymoma, the thoracoscopic surgery by subxiphoid approach is safe and effective, and can reduce the intraoperative blood loss and postoperative complications. CI - AJTR Copyright (c) 2021. FAU - Shen, Peng AU - Shen P AD - Department of Chest Surgery, Dongping Hospital Affiliated to Shandong First Medical University Dongping 271500, Shandong, China. FAU - Chen, Quan AU - Chen Q AD - Department of Oncology, Dongping Hospital Affiliated to Shandong First Medical University Dongping 271500, Shandong, China. FAU - Zhu, Fengwei AU - Zhu F AD - Department of General Surgery, Dongping Hospital Affiliated to Shandong First Medical University Dongping 271500, Shandong, China. FAU - Tang, Shouqi AU - Tang S AD - Department of General Surgery, Dongping Hospital Affiliated to Shandong First Medical University Dongping 271500, Shandong, China. FAU - Zhang, Xuxian AU - Zhang X AD - Department of Chest Surgery, Dongping Hospital Affiliated to Shandong First Medical University Dongping 271500, Shandong, China. FAU - Li, Feng AU - Li F AD - Department of Oncology, Dongping Hospital Affiliated to Shandong First Medical University Dongping 271500, Shandong, China. LA - eng PT - Journal Article DEP - 20211115 PL - United States TA - Am J Transl Res JT - American journal of translational research JID - 101493030 PMC - PMC8661206 OTO - NOTNLM OT - Subxiphoid approach OT - clinical efficacy OT - postoperative complications OT - thymoma COIS- None. EDAT- 2021/12/28 06:00 MHDA- 2021/12/28 06:01 PMCR- 2021/11/15 CRDT- 2021/12/27 06:27 PHST- 2021/07/22 00:00 [received] PHST- 2021/09/27 00:00 [accepted] PHST- 2021/12/27 06:27 [entrez] PHST- 2021/12/28 06:00 [pubmed] PHST- 2021/12/28 06:01 [medline] PHST- 2021/11/15 00:00 [pmc-release] PST - epublish SO - Am J Transl Res. 2021 Nov 15;13(11):12843-12851. eCollection 2021.